Amid Headline Risk, Barclays Says St. Jude's Pipeline Underestimated By: Benzinga via Benzinga October 20, 2016 at 13:41 PM EDT Barclays believes investors are underestimating St. Jude Medical, Inc. (NYSE: STJ)’s pipeline and growth potential in future ... Read More >> Related Stocks: Abbott Laboratories St. Jude Medical